Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
AMAM | Ambrx Biopharma, Inc. | Chief Financial Officer | $0 | Mar 7, 2024 | ||
AMAM | Ambrx Biopharma Cayman, Inc. | Chief Financial Officer | Jul 5, 2023 | |||
MOTS | Motus GI Holdings, Inc. | Director | Mar 5, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|